Hemab Therapeutics ApS is an emerging biotech company supported by Novo Holdings A/S with the aim of developing novel treatments for rare and underserved bleeding disorders. Based in Copenhagen, the company is led by a team of drug developers and scientists with deep expertise in haemophilia. Hemab has exclusive licences to state-of-the-art antibody technologies from both Novo Nordisk A/S and Genmab A/S.

Biotechnology

Life Sciences

Pharmaceutical

Hemab

Hemab's headquarters in Copenhagen, Denmark

Benny Sorensen

Mads Behrndt

Kate Madigan

Kathryn Zwetchkenbaum

Cécile Bonvoisin

Henrik Østergaard

John Maraganore

Linda Bain

Uya Chuluunbaatar

Christine Borowski

Jørgen Søberg Petersen

Mårten Steen

Laura Tadvalkar

Shan Wang

Camilla Petrycer Hansen

Dan Becker

The Manufacturing and Development Team at Hemab Therapeutics is responsible for the seamless transition of novel therapies from concept to clinical application. This team focuses on optimizing drug manufacturing processes, ensuring analytical development meets regulatory standards, and overseeing drug substance production. By collaborating closely with regulatory affairs and clinical leadership, they strive to bring innovative treatments for rare bleeding disorders to market efficiently and effectively.

Manufacturing and Development Team

The Clinical Research Team at Hemab Therapeutics is responsible for designing, implementing, and overseeing clinical trials that evaluate the safety and efficacy of novel treatments for rare bleeding disorders. Comprising experienced professionals in clinical operations and research, the team collaborates closely with regulatory bodies and research institutions to ensure compliance and the advancement of innovative therapies, ultimately aiming to improve patient outcomes in underserved medical conditions.

Clinical Research Team

The Leadership Team at Hemab Therapeutics is responsible for driving the company's strategic vision and operational direction in the development of innovative treatments for rare bleeding disorders. Comprising experts in drug development, regulatory affairs, manufacturing, and financial management, the team collaborates to ensure the successful progression of research initiatives, compliance with regulatory standards, and the effective allocation of resources, all aimed at delivering transformative therapies to patients in need.

Leadership Team

The Finance and Accounting Team at Hemab is responsible for managing the company's financial health and ensuring compliance with regulatory standards. They oversee budgeting, forecasting, and financial reporting, while also handling accounting activities to support strategic decision-making. The team collaborates closely with other departments to facilitate resource allocation and drive financial performance as the company develops innovative treatments for bleeding disorders.

Finance and Accounting Team

The Medical Affairs Team at Hemab is responsible for bridging clinical research and patient care by providing scientific and medical expertise on bleeding disorders. They engage with healthcare professionals and stakeholders to disseminate important data about Hemab's therapies, ensure compliance with regulatory standards, and support clinical trials. Their efforts help to advance understanding and accessibility of innovative treatments for patients with rare bleeding disorders.

Hemab

Org chart

Board & advisors

Teams

Manufacturing and Development Team

Clinical Research Team

Leadership Team

Finance and Accounting Team

Medical Affairs Team

Offices

Hemab

Org chart

Board & advisors

Teams

Manufacturing and Development Team

Clinical Research Team

Leadership Team

Finance and Accounting Team

Medical Affairs Team

Offices

Related companies